IADI
LIVE

Serial Number

99615597

Owner

Robert Dahmes

Attorney

Thomas E. Lemler

Filing Date

Jan 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

IADI Trademark

Serial Number: 99615597

IADI is a trademark filed by Robert Dahmes on January 26, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Robert Dahmes

2401 Cumberland Ct
New Orleans, LA 70131

Entity Type: 01

Trademark Details

Filing Date

January 26, 2026

Registration Date

Not Registered

Published for Opposition

June 23, 2026

Goods & Services

Providing medical information in the field of medication safety, drug interactions, and pharmacologic risk assessment; Providing medical information in the field of pharmaceuticals, namely, providing medical information regarding multi-variable medication risk synthesis; Providing a web site featuring medical information; Providing medical information via a website; Provision of medical information; Providing medical information in the field of medical reports, namely, generating informational summaries regarding medication interaction risks for patients and caregivers; Health care services, namely, providing information regarding potential adverse drug interactions and risk stratification to support medical decision-making; Health care services, namely, preparation of medical reports by generating informational summaries regarding medication interaction risks for patients and caregivers; Health care services, namely, provision of pharmaceutical information regarding drug interactions and pharmacologic risk assessment

Downloadable mobile applications for analyzing and synthesizing medical data to identify medication risks; Downloadable mobile applications for aggregating multi-variable pharmacologic data and generating informational decision-support outputs; Downloadable mobile applications for providing educational summaries regarding medication interactions and risk stratification; Downloadable mobile applications for use in the field of healthcare for tracking, managing, and analyzing patient medication regimens and associated risk factors; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software for analyzing and synthesizing medical data to identify medication risks; Downloadable computer software for aggregating multi-variable pharmacologic data and generating informational decision-support outputs; Downloadable computer software for providing educational summaries regarding medication interactions and risk stratification; Downloadable computer software for use in the field of healthcare for tracking, managing, and analyzing patient medication regimens and associated risk factors

Software as a service (SAAS) services featuring software for analyzing, aggregating, and synthesizing multi-variable medical and pharmacologic data; Software as a service (SAAS) services featuring software for healthcare data analysis and risk stratification in the field of medication safety; Software as a service (SAAS) services featuring software for evaluating concurrent pharmacologic agents and contextual variables to assess health risks; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for evaluating concurrent pharmacologic agents and contextual variables to assess health risks; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for analyzing, aggregating, and synthesizing multi-variable medical and pharmacologic data; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for healthcare data analysis and risk stratification in the field of medication safety; Providing temporary use of online non-downloadable simulation software for modeling medication interaction risk summaries and decision-support outputs; Providing temporary use of online non-downloadable computer software for generating medication interaction risk summaries and decision-support outputs; Providing temporary use of online non-downloadable computer software applications for generating medication interaction risk summaries and decision-support outputs; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for generating medication interaction risk summaries and decision-support outputs; Platform as a service (PAAS) featuring computer software platforms for evaluating concurrent pharmacologic agents and contextual variables to assess health risks; Platform as a service (PAAS) featuring computer software platforms for analyzing, aggregating, and synthesizing multi-variable medical and pharmacologic data; Platform as a service (PAAS) featuring computer software platforms for generating medication interaction risk summaries and providing decision-support outputs; Providing a web site featuring technology that enables users to aggregate multi-variable pharmacologic data and generate informational decision-support outputs

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2026 CNSA
ASSIGNED TO EXAMINER
May 22, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2026 NWOS
NEW APPLICATION ENTERED
Jan 26, 2026 NWAP
APPLICATION FILING RECEIPT MAILED
Jan 26, 2026 MAFR